一般医生对生活方式干预的观点,以预防痴呆症的认知维护
Josefine Kappe1, Felix Wittmann2, Melanie Luppa2
1Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Phillip-Rosenthal-Str. 55, Leipzig, 04103, Germany. Josefine.Kappe@medizin.uni-leipzig.de.
BMC primary care
|August 14, 2024
概括
一般医生 (GPs) 认为生活方式的改变可以保持认知表现,高度评价身体和社会活动. 年龄较大的全科医生对营养的信念更强烈.
科学领域:
- 老年学是一门学科.
- 公共卫生 公共卫生
- 一般的做法一般的做法
背景情况:
- 一般医生对于检测认知障碍和痴呆症以及提供诊断后护理至关重要.
- 这项研究探讨了全科医生对生活方式干预认知健康及其与全科医生年龄的关系的看法.
研究的目的:
- 调查全科医生 (GPs) 如何看待生活方式变化在维持认知表现方面的潜力.
- 评估全科医生对可修改的健康和生活方式因素对认知健康的有效性的信念.
- 为了确定医生对生活方式干预认知健康的信念是否因年龄而异.
主要方法:
- 来自AgeWell.de试验的72名全科医生完成了一份关于改变生活方式以保持认知能力的问卷.
- 风险和保护因素的感知有效性使用5分利克尔特尺度表来衡量.
- 用描述性统计学,斯皮尔曼的等级相关性和顺序逻辑回归来分析数据.
主要成果:
- 一般医生对生活方式改变对认知表现的整体影响持中立的观点 (中位数=3.0).
- 一般医生对所有可修改因素的有效性进行了高度评价,身体和社会活动获得了最高分 (中位数=5.0).
- 在GP年龄和对营养优化为预防认知衰退的信念之间发现了积极的相关性 (ρ=0.255,p=0.041),尽管年龄没有显著影响整体疗效评级.
结论:
- 普通医生通常认为可修改的健康和生活方式因素在预防认知衰退和痴呆症方面是有效的.
- 整体医生认为体力活动和社交活动是特别有影响力的生活方式干预措施.
更多相关视频
07:01Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
4.7K
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.3K
相关概念视频
01:30Dementia
108
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
108
01:20Lifestyle Factors and Health
41
Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
41
01:22Alzheimer's Disease: Treatment
171
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
171
01:30Cognitive Development During Adulthood
72
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
72
01:26Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
111
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
111